RESUMO
This pilot study assessed the impact of diabetes on overall quality of life (QOL) of 23 adolescents (12-16 years old). The impact of diabetes on daily life, satisfaction with life, and common worries and frustrations were explored through the Diabetes Quality of Life for Youth scale (DQOLY) and semistructured interviews. The four major themes that emerged from the interviews were (a) restrictions, (b) differentness, (c) negative emotion, and (d) adaptation. Adolescents reported being most bothered by dietary restrictions, including the regimentation/scheduling of eating and its social ramifications. Adolescents in this study worried the most about the future and, in particular, complications. Older adolescents worried less, had lower Diabetes Impact scores, and had better Quality of Life scores on the DQOLY. The theme of adaptation and the negative emotion theme were both expressed most often by participants who had had diabetes for a longer period of time.
Assuntos
Diabetes Mellitus Tipo 1/enfermagem , Diabetes Mellitus Tipo 1/psicologia , Qualidade de Vida , Adaptação Psicológica , Adolescente , Fatores Etários , Criança , Estudos de Coortes , Diabetes Mellitus Tipo 1/fisiopatologia , Feminino , Humanos , Masculino , Estudos de Amostragem , Autoimagem , Índice de Gravidade de Doença , Fatores Sexuais , Inquéritos e QuestionáriosRESUMO
Results of the Diabetes Control and Complications Trial announced in June 1993 provide convincing evidence that achievement of near-normal glycemic levels in insulin-dependent diabetic individuals decreases the microvascular complications of diabetes. School nurses should expect some changes in management of diabetes to emerge in the near future, with requirements for increased expertise and closer communication with diabetes care providers.
Assuntos
Diabetes Mellitus Tipo 1/prevenção & controle , Serviços de Enfermagem Escolar/métodos , Criança , Diabetes Mellitus Tipo 1/complicações , Humanos , Insulina/uso terapêuticoRESUMO
Recent data suggests that one of the major actions of sulfonylureas is to potentiate the anabolic cellular effects of insulin. This is the first study to examine the use of sulfonylureas as adjunctive therapy in newly-diagnosed type I diabetic children. A random, prospective, double blind study over 15 months, stratified by age at diagnosis, was conducted. The treatment group (n = 13) received daily oral weight-adjusted tolazamide whereas the control group (n = 11) received placebo. Monthly comparison of the HbA1 values between groups revealed no statistical difference; likewise, the fasting serum C-peptide values were not dissimilar. The mean daily insulin dose per kilogram, however, was less in the tolazamide group (P less than 0.001). The data suggests that the addition of tolazamide may not be of therapeutic benefit in newly diagnosed juvenile diabetics, although insulin requirements may be reduced.
